These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Potentiation of tolbutamide by dicumarol. Sise HS. Ann Intern Med; 1967 Aug; 67(2):460-1. PubMed ID: 4166650 [No Abstract] [Full Text] [Related]
3. Potentiation of the tolbutamide effect by dicoumarol. Kristensen M, Hansen JM. Diabetes; 1967 Apr; 16(4):211-4. PubMed ID: 4164590 [No Abstract] [Full Text] [Related]
4. [On a case of hypoglycemic coma in the course of tolbutamide and dicoumarol therapy]. Fontana G, Addarii F, Peta G. G Clin Med; 1968 Sep; 49(9):849-58. PubMed ID: 4180318 [No Abstract] [Full Text] [Related]
5. The choice of an oral anticoagulant. Drug Ther Bull; 1972 Mar 31; 10(7):25-8. PubMed ID: 4114149 [No Abstract] [Full Text] [Related]
6. Anticoagulant therapy and indication. Rickard KA. Southeast Asian J Trop Med Public Health; 1979 Sep 31; 10(3):342-7. PubMed ID: 92807 [No Abstract] [Full Text] [Related]
7. [The dynamics of insulinemia in man after administration of tolbutamide]. Lenti G, Pellegrini A, Pagano G, Mascia V, Cirillo R. Minerva Med; 1968 Feb 03; 59(10):479-87. PubMed ID: 5642230 [No Abstract] [Full Text] [Related]
12. [Comparative anti-inflammatory action of anticoagulant substances. Mode of action of phenylindanedione]. Fontaine L, Grand M, Quentin Y, Merle S. Med Pharmacol Exp Int J Exp Med; 1965 Feb 03; 13(3):137-54. PubMed ID: 4157600 [No Abstract] [Full Text] [Related]
20. Experimental studies on the spread of cancer, with special reference to fibrinolytic agents and anticoagulants. Wood S. J Med; 1974 Feb 03; 5(1):7-22. PubMed ID: 4134042 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]